Form D · Biotechnology

SutroVax, Inc.

Foster City, CA · CIK 0001649094

Offering snapshot reported Apr 3, 2020 · SEC filing

Reported sold
$110M
Offering amount: $110M
Investors reported
23
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 20, 2020
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 3, 2020Initial$110,000,000No comparison23SEC filing
Jun 12, 2018Initial$43,182,959No comparison12SEC filing
Mar 21, 2017Initial$40,100,007No comparison9SEC filing
Jul 24, 2015Initial$12,634,755No comparison7SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-364301

Source: Form D, filed Apr 3, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Durga P Bobba Executive
Patrick Enright Director
Jeff Fairman Executive
Patrick J Heron Director
Peter Hirth Director
Rob Hopfner Director
Ashish Khanna Executive
Heath Lukatch Director
William Newell Director
Grant E Pickering Director, Executive
Tracy Saxton Director
Moncef Slaoui Director
Elaine Sun Executive
Kurt Von Emster Director
James P Wassil Executive
Jane Wright Mitchell Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
353 Hatch Dr
Foster City, CA, 94404